Source: Health Canada shortage reports · Updated Jul 13, 2026
Some Indapamide products are in shortage in Canada (3 of 14 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A diuretic (water pill) used to lower blood pressure.
Products affected
3 / 14
In shortage since
Sep 15, 2016
Reports on file
56
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
MYLAN-INDAPAMIDE
1.25MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02240067 · since ?, est. end Jul 21, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-INDAPAMIDE
1.25MG · TABLET · JAMP PHARMA CORPORATION
DIN 02373904 · since Sep 15, 2016, est. end Dec 31, 2020 · Supply issues
Active shortage
JAMP-INDAPAMIDE
2.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02373912 · since Sep 15, 2016, est. end Dec 31, 2020 · Supply issue
Active shortage
JAMP-INDAPAMIDE
2.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02373912 · since Sep 15, 2016, est. end Dec 31, 2020
Active shortage
JAMP-INDAPAMIDE
2.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02373912 · since Sep 15, 2016, est. end Dec 31, 2020 · supply issue
Resolved
RIVA-INDAPAMIDE 1.25
1.25MG · TABLET · LABORATOIRE RIVA INC
DIN 02247245 · ended Apr 1, 2026 · Disruption of the manufacture of the drug.
Resolved
RIVA-INDAPAMIDE 2.5 MG
2.5MG · TABLET · LABORATOIRE RIVA INC
DIN 02242125 · ended Apr 1, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-INDAPAMIDE
1.25MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02240067 · ended Apr 17, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-INDAPAMIDE
2.5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02153483 · ended Mar 30, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-INDAPAMIDE
1.25MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02240067 · ended Nov 26, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-INDAPAMIDE
2.5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02153483 · ended Oct 8, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-INDAPAMIDE
1.25MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02240067 · ended Sep 3, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 56 reports. All reports are on file with Health Canada.
What's happening
Indapamide is currently affected by 3 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC, JAMP PHARMA CORPORATION.
The reported causes are: disruption of the manufacture of the drug; supply issues; supply issue; supply issue. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Indapamide is classified under “LOW-CEILING DIURETICS, EXCL THIAZIDES” (ATC C03BA).
Recent changes
Jul 13, 2026
Status changed
Common questions
What is Indapamide used for?
A diuretic (water pill) used to lower blood pressure.
When will Indapamide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Indapamide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.